Atherogenic LOX-1 Signaling is Controlled by SPPL2-mediated Intramembrane Proteolysis
Overview
General Medicine
Authors
Affiliations
The lectin-like oxidized LDL receptor 1 (LOX-1) is a key player in the development of atherosclerosis. LOX-1 promotes endothelial activation and dysfunction by mediating uptake of oxidized LDL and inducing pro-atherogenic signaling. However, little is known about modulators of LOX-1-mediated responses. Here, we show that the function of LOX-1 is controlled proteolytically. Ectodomain shedding by the metalloprotease ADAM10 and lysosomal degradation generate membrane-bound N-terminal fragments (NTFs), which we identified as novel substrates of the intramembrane proteases signal peptide peptidase-like 2a and b (SPPL2a/b). SPPL2a/b control cellular LOX-1 NTF levels which, following self-association via their transmembrane domain, can activate MAP kinases in a ligand-independent manner. This leads to an up-regulation of several pro-atherogenic and pro-fibrotic targets including ICAM-1 and the connective tissue growth factor CTGF. Consequently, SPPL2a/b-deficient mice, which accumulate LOX-1 NTFs, develop larger and more advanced atherosclerotic plaques than controls. This identifies intramembrane proteolysis by SPPL2a/b as a novel atheroprotective mechanism via negative regulation of LOX-1 signaling.
The Dectin-1 and Dectin-2 clusters: C-type lectin receptors with fundamental roles in immunity.
Malamud M, Brown G EMBO Rep. 2024; 25(12):5239-5264.
PMID: 39482490 PMC: 11624271. DOI: 10.1038/s44319-024-00296-2.
Selective regulation of aspartyl intramembrane protease activity by calnexin.
Contreras W, Groenendyk J, Gentzel M, Schonberg P, Buchholz F, Michalak M Cell Mol Life Sci. 2024; 81(1):441.
PMID: 39460794 PMC: 11513070. DOI: 10.1007/s00018-024-05478-8.
Leinung N, Mentrup T, Patel M, Gallagher T, Schroder B iScience. 2023; 26(10):107819.
PMID: 37736044 PMC: 10509304. DOI: 10.1016/j.isci.2023.107819.
Contreras W, Bazan J, Mentrup T Cell Mol Life Sci. 2023; 80(6):170.
PMID: 37261541 PMC: 10234869. DOI: 10.1007/s00018-023-04823-7.
ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?.
Maas S, Donners M, van der Vorst E Int J Mol Sci. 2023; 24(8).
PMID: 37108478 PMC: 10139114. DOI: 10.3390/ijms24087309.